Molecularly Targeted Anti-Cancer Therapies

Project Title Molecularly Targeted Anti-Cancer Therapies
Date Posted
Wednesday, January 24, 2018
Project ID
MSY4_STR045-046
Status
Complete
Deliverables
Description

These reports look at the use of 18 selected generic drug products relating to molecularly targeted anti-cancer therapies in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. This query was run against the Dispensing Summary Table and distributed on May 10, 2013 to 17 Data Partners; this report includes information from 17 Data Partners. 

Medical Product
axitinib
bicalutamide
crizoatinib
dasatinib
erlotinib HCL
everolimus
gefitinib
imatinib mesylate
lapatinib ditosylate
nilotinib HCL
pazopanib HCL
ruxolitinib phosphate
sorafenib tosylate
sunitinib malate
tamoxifen citrate
vandetanib
vemurafenib
vismodegib
Population / Cohort
All individuals
Time Period
2000 - 2012
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top